亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes

表型 肿瘤微环境 生物 癌症研究 遗传异质性 细胞毒性T细胞 肿瘤进展 癌症 肿瘤细胞 病理 体外 医学 遗传学 基因
作者
Mark Robertson‐Tessi,Robert J. Gillies,Robert A. Gatenby,Alexander R.A. Anderson
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:75 (8): 1567-1579 被引量:259
标识
DOI:10.1158/0008-5472.can-14-1428
摘要

Abstract Histopathologic knowledge that extensive heterogeneity exists between and within tumors has been confirmed and deepened recently by molecular studies. However, the impact of tumor heterogeneity on prognosis and treatment remains as poorly understood as ever. Using a hybrid multiscale mathematical model of tumor growth in vascularized tissue, we investigated the selection pressures exerted by spatial and temporal variations in tumor microenvironment and the resulting phenotypic adaptations. A key component of this model is normal and tumor metabolism and its interaction with microenvironmental factors. The metabolic phenotype of tumor cells is plastic, and microenvironmental selection leads to increased tumor glycolysis and decreased pH. Once this phenotype emerges, the tumor dramatically changes its behavior due to acid-mediated invasion, an effect that depends on both variations in the tumor cell phenotypes and their spatial distribution within the tumor. In early stages of growth, tumors are stratified, with the most aggressive cells developing within the interior of the tumor. These cells then grow to the edge of the tumor and invade into the normal tissue using acidosis. Simulations suggest that diffusible cytotoxic treatments, such as chemotherapy, may increase the metabolic aggressiveness of a tumor due to drug-mediated selection. Chemotherapy removes the metabolic stratification of the tumor and allows more aggressive cells to grow toward blood vessels and normal tissue. Antiangiogenic therapy also selects for aggressive phenotypes due to degradation of the tumor microenvironment, ultimately resulting in a more invasive tumor. In contrast, pH buffer therapy slows down the development of aggressive tumors, but only if administered when the tumor is still stratified. Overall, findings from this model highlight the risks of cytotoxic and antiangiogenic treatments in the context of tumor heterogeneity resulting from a selection for more aggressive behaviors. Cancer Res; 75(8); 1567–79. ©2015 AACR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
曾经寄文发布了新的文献求助10
4秒前
5秒前
xwwwww发布了新的文献求助10
10秒前
ding应助小雪采纳,获得10
11秒前
困得想薯完成签到,获得积分10
24秒前
研友_892kOL完成签到,获得积分10
32秒前
33秒前
36秒前
40秒前
领导范儿应助科研通管家采纳,获得10
41秒前
41秒前
我是老大应助科研通管家采纳,获得10
42秒前
完美世界应助科研通管家采纳,获得10
42秒前
英俊的铭应助科研通管家采纳,获得10
42秒前
Chloe应助科研通管家采纳,获得10
42秒前
45秒前
46秒前
GibsonYu发布了新的文献求助10
49秒前
球球发布了新的文献求助10
49秒前
violet完成签到,获得积分10
54秒前
健忘的寄瑶完成签到,获得积分10
1分钟前
1分钟前
下午好完成签到 ,获得积分10
1分钟前
diaoyulao完成签到,获得积分10
1分钟前
若尘完成签到 ,获得积分10
1分钟前
西西弗斯完成签到,获得积分0
1分钟前
丘比特应助番茄酱采纳,获得10
1分钟前
氯丙嗪完成签到 ,获得积分10
1分钟前
眼睛大迎松完成签到,获得积分10
1分钟前
早睡早起完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
2分钟前
隐形曼青应助球球采纳,获得10
2分钟前
2分钟前
熊星星完成签到 ,获得积分10
2分钟前
2分钟前
小雪发布了新的文献求助10
2分钟前
2分钟前
2分钟前
高分求助中
Impact of Mitophagy-Related Genes on the Diagnosis and Development of Esophageal Squamous Cell Carcinoma via Single-Cell RNA-seq Analysis and Machine Learning Algorithms 2000
How to Create Beauty: De Lairesse on the Theory and Practice of Making Art 1000
Gerard de Lairesse : an artist between stage and studio 670
大平正芳: 「戦後保守」とは何か 550
2019第三届中国LNG储运技术交流大会论文集 500
Contributo alla conoscenza del bifenile e dei suoi derivati. Nota XV. Passaggio dal sistema bifenilico a quello fluorenico 500
Multiscale Thermo-Hydro-Mechanics of Frozen Soil: Numerical Frameworks and Constitutive Models 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 2997737
求助须知:如何正确求助?哪些是违规求助? 2658273
关于积分的说明 7195862
捐赠科研通 2293571
什么是DOI,文献DOI怎么找? 1216071
科研通“疑难数据库(出版商)”最低求助积分说明 593428
版权声明 592877